Analytically confirmed exposure to novel psychoactive substances in patients presenting to hospital with severe clinical toxicity in the United Kingdom. Results from the Identification Of Novel psychoActive substances (IONA) study

被引：0

作者：

Thomas, Simon ^{[1
]}

Dunn, Michael ^{[1
]}

Hill, Simon L. ^{[1
]}

Abouchedid, Rachelle ^{[2
,3
,4
]}

Dargan, Paul ^{[2
,3
,4
]}

Wood, David ^{[2
,3
,4
]}

Acheampong, Paul ^{[5
]}

Kamour, Ashraf ^{[6
]}

Tucker, Simon ^{[7
]}

Grundlingh, Johann ^{[8
]}

Officer, Jane ^{[9
]}

Eddleston, Michael ^{[10
]}

机构：

[1] Newcastle Univ, Med Toxicol Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[2] Guys & St Thomas NHS Fdn Trust, Clin Toxicol, London, England

[3] Kings Hlth Partners, London, England

[4] Kings Coll London, Fac Life Sci & Med, London, England

[5] Royal Liverpool Univ Hosp, Prescot St, Liverpool L7 8XP, Merseyside, England

[6] North Manchester Gen Hosp, Delaunays Rd, Manchester M8 5RB, Lancs, England

[7] Blackpool Teaching Hosp NHS Fdn Trust, Blackpool Victoria Hosp, Blackpool FY3 8NR, England

[8] Royal London Hosp, Emergency Dept, London, England

[9] Scottish Police Author Forens Serv, Edinburgh, Midlothian, Scotland

[10] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland

来源：

CLINICAL TOXICOLOGY | 2016年 / 54卷 / 08期

关键词：

Novel psychoactive substances; drug misuse; synthetic cannabinoid receptor agonists;

D O I：

暂无

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：713 / +

页数：2

共 13 条

[1] Identification of novel psychoactive substances in biological samples from patients with severe clinical toxicity in the UK: preliminary results from the Identification Of Novel psychoActive substances (IONA) study
Hill, Simon L.
Dunn, Michael
Najafi, Javad
Abouchedid, Rachelle
Dargan, Paul I.
Wood, David M.
Thomas, Simon H. L.
CLINICAL TOXICOLOGY, 2016, 54 (04) : 380 - 380
[2] Changes with time in analytically confirmed exposure to novel psychoactive substances in patients with severe clinical toxicity in the UK
Dunn, Michael
Hill, Simon
Tucker, Simon
Dargan, Paul
Wood, David M.
Grundlingh, Johann
Jarman, Heather
Keating, Liza
Baombe, Janos
Adeboye, Kayode
Eddleston, Michael
Officer, Jane
Thomas, Simon
CLINICAL TOXICOLOGY, 2017, 55 (07) : 799 - 799
[3] Acute toxicity following analytically confirmed use of the novel psychoactive substance (NPS) methiopropamine: a report from the Identification Of Novel psychoActive substances (IONA) study
White, Joanna
Dargan, Paul I.
Wood, David M.
Hill, Simon L.
Biswell, Elizabeth
Archer, John R. H.
Dunn, Michael D.
Thomas, Simon H. L.
CLINICAL TOXICOLOGY, 2018, 56 (06) : 461 - 462
[4] Changes with time in analytically confirmed exposure to novel psychoactive substances (NPS) in patients with severe clinical toxicity in the UK
Thomas, Simon H. L.
Dunn, Michael D.
Hill, Simon L.
Tucker, Simon
Wood, David M.
Dargan, Paul I.
Grundlingh, Johann
Jarman, Heather
Keating, Liza
Kataria, Himanshu
Eddleston, Michael
Officer, Jane
Cooper, Jamie
Baombe, Janos
Thornley, Jonathan
Parris, Richard
CLINICAL TOXICOLOGY, 2018, 56 (06) : 499 - 500
[5] Acute toxicity following analytically confirmed use of the novel psychoactive substance (NPS) methiopropamine. A report from the Identification of Novel psychoActive substances (IONA) study
White, Joanna C.
Wood, David M.
Hill, Simon L.
Eddleston, Michael
Officer, Jane
Dargan, Paul I.
Dunn, Michael
Thomas, Simon H. L.
CLINICAL TOXICOLOGY, 2019, 57 (07) : 663 - 667
[6] Analytically-confirmed exposure to new psychoactive substances in patients with severe clinical toxicity in the UK, 2015-2018: a report from the IONA study
Vidler, Daniel
Dunn, Michael
Officer, Jane
Roper, Clair
Hill, Simon L.
Dargan, Paul I.
Wood, David M.
Eddleston, Michael
Thomas, Simon H. L.
CLINICAL TOXICOLOGY, 2020, 58 (06) : 595 - 596
[7] Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study
Hill, Simon L.
Najafi, Javad
Dunn, Michael
Acheampong, Paul
Kamour, Ashraf
Grundlingh, Johann
Blain, Peter G.
Thomas, Simon H. L.
CLINICAL TOXICOLOGY, 2016, 54 (08) : 638 - 643
[8] Synthetic cannabinoid receptor agonists identified in patients with severe clinical toxicity in England: a report from the Identification Of Novel psychoActive substances (IONA) study
Hill, Simon L.
Dunn, Michael
Dargan, Paul I.
Wood, David M.
Tucker, Simon
Grundlingh, Johann
Kamour, Ashraf
Acheampong, Paul
Thomas, Simon H. L.
CLINICAL TOXICOLOGY, 2017, 55 (05) : 452 - 452
[9] Changes with time in the novel psychoactive substances identified in British patients presenting with severe clinical toxicity
Thomas, Simon
Cooper, Jamie
Dargan, Paul
Eddleston, Michael
Grundlingh, Johann
Hill, Simon
Jarman, Heather
Keating, Liza
Tucker, Simon
Wood, David
Officer, Jane
Dunn, Michael
CLINICAL TOXICOLOGY, 2018, 56 (10) : 980 - 981
[10] Reduction in analytically confirmed exposures to new psychoactive substances in patients attending emergency departments with severe clinical toxicity in the United Kingdom, 2015-2019
Thomas, Simon
Vidler, Dan
Dunn, Michael
Officer, Jane
Hudson, Simon
Hill, Simon L.
Hardy, Gareth
Dargan, Paul I.
Wood, David M.
Haden, Mark
Keating, Liza
Eddleston, Michael
Macfarlane, Rebecca G.
Cooper, Jamie G.
CLINICAL TOXICOLOGY, 2020, 58 (11) : 1082 - 1083

← 1 2 →